Antioxidant N ‐acetylcysteine as an intervention for neuropsychiatric symptoms in individuals with vascular mild cognitive impairment

Abstract

Background: Neuropsychiatric symptoms (NPS) are non‐cognitive changes that often co‐occur with mild cognitive impairment (MCI) and independently increase the risk of progression to dementia. Of the NPS, apathy is a particularly strong risk factor.